NRx Pharmaceuticals, Inc. (NRXPW)

NASDAQ: NRXPW · Real-Time Price · USD · Warrants
0.142
+0.002 (1.50%)
Feb 18, 2025, 4:00 PM EST - Market closed
1.50%
Market Cap 34.37M
Revenue (ttm) n/a
Net Income (ttm) -20.39M
Shares Out 12.06M
EPS (ttm) -2.12
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,119
Open 0.146
Previous Close 0.140
Day's Range 0.142 - 0.146
52-Week Range 0.142 - 0.146
Beta 1.27
Analysts n/a
Price Target n/a
Earnings Date Mar 28, 2025

About NRXPW

NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. Its products include NRX-101 (D-cycloserine/Lurasidone), an oral, fixed dosed combination of D-cycloserine and lurasidone that earned food and drug administration-designated breakthrough therapy for suicidal treatment-resistant bipolar depression; and NRX-100 (ketamine), which has been awarded FDA fast track desi... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Country United States
Stock Exchange NASDAQ
Ticker Symbol NRXPW
Full Company Profile

Financial Performance

News

There is no news available yet.